GL1X · GenesisL1 explorer

Research workbench

Crystal structure of a human factor xa inhibitor complex

Analyse Crystal structure of a human factor xa inhibitor complex in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2J4I
Type
protein
Length
284 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Coagulation factor X
EC
3.4.21.6
UniProt
P00742
Ligands
GSJ, CA
Pockets
2 · best druggability 0.48

Structure

x-ray diffraction · 2 distinct chains · 14% helix, 37% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACoagulation factor X (EC 3.4.21.6)protein23214% helix, 38% strandP00742
BCoagulation factor X (EC 3.4.21.6)protein5213% helix, 31% strandP00742

Ligands and binding sites

  • GSJ · 1-pyrrolidineacetamide, 3-[[(6-chloro-2-naphthalenyl)sulfonyl]amino]-alpha-methyl-N-(1-methylethyl)-N-[2-[(methylsulfonyl)amino]ethyl]-2-oxo-, (alphas,3s)- · ligand · chains A
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11750.480.7628empty
21080.460.7923GSJ

Interfaces

1 interface between chains.

  • A–B · 925 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 2J4I · Crystal structure of a human factor xa inhibitor complex · the same entry in another collection · chain A against A, TM-score 1.00
  • P00742 · AlphaFold monomer V2.0 prediction for coagulation factor X (P00742) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.